Incyte
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.About INCY
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.
INCY Key Statistics
Stock Snapshot
With a market cap of 24.36B, Incyte(INCY) trades at $120.16. The stock has a price-to-earnings ratio of 62.15.
During the trading session on 2026-10-30, Incyte(INCY) shares reached a daily high of $122.87 and a low of $119.40. At a current price of $120.16, the stock is +0.6% higher than the low and still -2.2% under the high.
Trading activity shows a volume of 974.18K, compared to an average daily volume of 1.86M.
The stock's 52-week range extends from a low of $89.25 to a high of $132.60.
The stock's 52-week range extends from a low of $89.25 to a high of $132.60.
INCY News
...
Incyte (INCY) has moved back into focus after presenting Phase 1 data at the ESMO 2026 Congress on two gastrointestinal oncology assets, along with new combinat...
Genmab and Incyte recently announced a clinical trial collaboration to test petosemtamab with Incyte’s KRAS G12D inhibitor INCB161734 plus standard chemotherapy...
Analyst ratings
48%
of 31 ratingsMore INCY News
Incyte (NasdaqGS: INCY) and Genmab agreed a new clinical trial collaboration to study treatments for KRAS G12D-mutated metastatic colorectal cancer. The partne...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.